India, June 16 -- image credit- freepik

In a significant step towards strengthening India's regenerative healthcare ecosystem, Gurugram-based Cryoviva Life Sciences has introduced PrepaCyte-CB(R) technology in India through an exclusive partnership, aiming to redefine the standards of cord blood stem cell preservation with a stronger focus on quality, recovery, and long-term clinical relevance.

With the introduction of PrepaCyte-CB(R), Cryoviva aims to address this critical gap by providing Indian families with broader access to a globally benchmarked technology aligned with advanced cord blood processing standards adopted across markets such as the US, Europe and Singapore.

The technology has demonstrated higher stem cell recovery, im...